INTRODUCTION
The control of foot and mouth disease (FMD) has to take into account the anti genic variation of the FMD virus. The study of antigenic variation among field viruses helps in understanding the epidemiology of FMD as also in the selection of suitable vaccine virus strains. Variation among type A strains has been reported by several authors (1, 3, 4, 12) . In India, prevalence of types О, С and A FMD virus and their variants was first recorded by Seetharaman and Datt (11) . Type Asia 1 was reported in 1957 (6) . A quadrivalent vaccine was subsequently produced in the year 1965. While strains of Indian origin were incorporated for valences О, С and Asia 1, a Dutch type A strain was employed for the fourth valence (5) . This strain has been designated as A 5 or A iQ at various stages (5) . However, for the sake of cla rity, it is referred to as A Holland in the present study.
Type A strains isolated from outbreaks in cattle vaccinated with the afore mentioned vaccine were shown to be closer to the Middle Eastern A 22 subtype (5). Rweyemamu et al. (10) studied several Asian type A isolates from the Middle East and Indian sub-continent and observed that although the Indian type A FMD viru ses could be related to Middle Eastern A 22 virus (A 22 Iraq 24/64), they were quite divergent from each other. Limited strain differentiation studies showed that seve ral Indian type A isolates were closer to subtype A 22 than to the vaccine strain A Holland (2). * Indian Immunologicals, Hyderabad 500 004, India.
-724 -The present study was undertaken to: i) elucidate the antigenic relationship among Indian type A strains;
ii) evaluate the current vaccine strains and Hi) identify as candidate vaccine virus the strain(s) exhibiting a broad antigenic spectrum. 
MATERIALS AND METHODS

Viruses
Guinea-pig antisera
Anti 140S guinea-pig antisera against A 22 India 57/79 and A Holland were pre pared in our laboratory while those against A India 7/82 and A India 85/79 were obtained from Dr G.N. Mowat of AVRI, Pirbright, UK. The antisera were raised as per the method described by Rweyemamu et al. (7) . Briefly, BEI (binaryethyleneimine) inactivated and sucrose density gradient purified 140S antigen was emulsified with Freund's incomplete adjuvant and inoculated intramuscularly in the hind leg of guinea-pigs. A booster dose of similar 140S antigen was adminis tered 21 days later. Ten days after the second dose, the guinea-pigs were bled by exsanguination and the sera pooled before use.
Bovine vaccinate sera
A group of 6 seronegative steers were vaccinated with appropriate monovalent vaccine and boosted with the same on the 21st day. The animals were bled on the 35th day and the sera were pooled before use.
Serum neutralisation test
The two-dimensional microneutralisation test system, as described by Rweyemamu et al. (8), was used. The 'r' values -the ratio of serum neutralisation titre for heterologous and homologous virus -were calculated from the mean titres of three replicate tests. For testing the significance of V values an estimated, pooled variance of 0.106 (9) was used.
RESULTS
The 'r' values derived from replicate comparisons are furnished in Table II. The anti 140S guinea-pig antiserum raised against A 22 India 57/79 showed a narrow serological spectrum and all the viruses exhibited significant differences (r/1 at P = 0.01) when compared with A 22 India 57/79. The V values ranged from 0.01 to 0.17. Two isolates, namely A India 54/79 and A India 73/79, were found to be rela ted to A 22 India 57/79 when bovine vaccinate serum raised against A 22 India 57/79 was used. All other viruses were found to be significantly divergent from A 22 India 57/79 ('r' values ranging from 0.02 to 0.12). Strain A India 85/79 also showed a narrow serological spectrum and 'r' values significantly less than 1 (P = 0.01) were ob tained against all the strains.
Seven field strains were shown to be related to A India 7/82 when anti 140S guinea-pig serum was employed while the other seven were significantly divergent ('г' values ranging from 0.03 to 0.15).
All the Indian field strains were shown to be divergent from A Holland when anti 140S guinea-pig serum was used. Significantly low (P/0.01) 'r' values were also obtained with bovine vaccinate serum except in the case of A 22 India 57/79 with which A Holland appeared to have an asymmetric relationship.
Among the four strains used for reference, the strain A India 7/82 showed the broadest serological spectrum. 
DISCUSSION
The results of the study indicated that more than one distinct antigenic group within the serotype A may be prevalent in India. It can be observed that the strains A 22 India 57/79 and A India 85/79 have narrow serological spectra. The strain A 22 India 57/79, isolated from Southern India, appears to be related only to other strains of Southern Indian origin, namely A India 54/79 and A India 73/79. The strains from Maharashtra, namely A India 36/82 and A India 37/82, are divergent from A India 85/79 (r<l at P = 0.01), an isolate from Maharashtra which pre sents a narrow immunogenic spectrum against a majority of strains and cannot be considered as a candidate vaccine strain.
The strain A India 7/82, an isolate from Western India, exhibited a broader serological spectrum than the other two Indian strains (A 22 India 57/79 and A India 85/79) and A Holland. While the strains from Southern parts of India were neutra lised poorly (r < 1 at P = 0.01) by antiserum A India 7/82, all the strains from West ern and North Western parts of India, except A India 14/82 and A India 36/82, showed closer antigenic relationship to this strain. Although the strain A Holland exhibits an asymmetric relationship with A 22 India 57/79, its extremely narrow serological spectrum in relation to Indian isolates suggests that a more appropriate type A strain of Indian origin should be incorporated in the quadrivalent vaccine.
However, the wide diversity and complex interrelationship exhibited by Indian type A viruses in the present study supports the earlier observation by Rweyemamu et al. and makes the choice of an appropriate vaccine strain difficult. Keeping in mind that the uncontrolled livestock movements from one region to another play a major role in the spread of disease in India, it may be possible that the immunity provided by a single representative vaccine strain may be endangered if a variant strain is introduced. Therefore it is suggested that, in order to provide the broad immunogenic spectrum required, the type A strain to be incorporated in the quadri valent vaccine should be evaluated against representative isolates from various Indian territories and the immunocompetence of the vaccine strain should be moni tored continuously against the field strains. 
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